Document is current
Any future updates will be listed below
-
Authors
Jeandidier, Nathalie
Bagel, Arthur
Bonin, Alice
Guigand, Gabriel
Guerci, Bruno https://orcid.org/0000-0002-6211-464X
-
Funding
Funding for this research was provided by:
Insulet France
- License Information
-
More Information
Article History
Received: 11 August 2025
Accepted: 13 October 2025
First Online: 1 November 2025
Declarations
:
: Nathalie Jeandidier has received consulting fees from Timkl, Lilly, Medtronic. She has also received speaker or presenter fees from Lilly and One touch. Arthur Bagel declares no conflict of interest in relation to this work. Alice Bonin was employed by Insulet France SAS at the time of the study. Gabriel Guigand was employed by Insulet France SAS at the time of the study. Bruno Guerci has received consulting fees from Novo Nordisk, Sanofi, Lilly, GSK, Abbott, MSD, Roche Diagnostic, Boehringer Ingelheim, and Medtronic. He has also received speaker or presenter fees from Novo Nordisk, Sanofi, Lilly, GSK, Abbott, MSD, Roche Diagnostic, Boehringer Ingelheim, Medtronic, Vitalaire, and Orkyn. Training fees were received from Sanofi and Orkyn.
: This study was not subject to approval from a regulatory ethics committee, in accordance with article R1121-1 of the French Public Health Code. All procedures in this study complied with the laws and regulations regarding the management of personal information applicable in France, as well as the European General Data Protection Regulation.
